Accendra Health, Inc. Other Cost of Operating Revenue
Accendra Health, Inc. (ACH) reported Other Cost of Operating Revenue of $5.32 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OtherCostOfOperatingRevenue · last filed 2026-08-10
- Accendra Health, Inc. other cost of operating revenue for the quarter ending 2026-06-30 was $5.32M, a 10.04% decline year-over-year.
- Accendra Health, Inc. other cost of operating revenue for the quarter ending 2026-03-31 was $5.47M, a 1.78% decline year-over-year.
- Accendra Health, Inc. other cost of operating revenue for the quarter ending 2025-12-31 was $5.36M, a 13.68% decline year-over-year.
- Accendra Health, Inc. other cost of operating revenue for the quarter ending 2025-09-30 was $5.72M, a 9.53% decline year-over-year.
- Accendra Health, Inc. other cost of operating revenue for fiscal 2025 was $22.57M, a 17.19% decline from fiscal 2024.
- Accendra Health, Inc. other cost of operating revenue for fiscal 2024 was $27.25M, a 11.93% increase from fiscal 2023.
- Accendra Health, Inc. other cost of operating revenue for fiscal 2023 was $24.35M.
| Period end | Other Cost of Operating Revenue 3 month | Other Cost of Operating Revenue 6 month | Other Cost of Operating Revenue 9 month | Other Cost of Operating Revenue 12 month |
|---|---|---|---|---|
| 2026-06-30 | $5.32M 10-Q · filed 2026-08-10 | $10.79M 10-Q · filed 2026-08-10 | $16.15M derived: sum of 3 quarters · filed 2026-08-10 | $21.87M derived: sum of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | $5.47M 10-Q · filed 2026-05-11 | $10.83M derived: sum of 2 quarters · filed 2026-05-11 | $16.55M derived: sum of 3 quarters · filed 2026-05-11 | $22.47M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-12-31 | $5.36M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20 | $11.08M derived: sum of 2 quarters · filed 2026-02-20 | $17.00M derived: sum of 3 quarters · filed 2026-08-10 | $22.57M 10-K · filed 2026-02-20 |
| 2025-09-30 | $5.72M 10-Q · filed 2025-10-31 | $11.64M derived: sum of 2 quarters · filed 2026-08-10 | $17.21M 10-Q · filed 2025-10-31 | $23.41M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-06-30 | $5.92M 10-Q · filed 2026-08-10 | $11.48M 10-Q · filed 2026-08-10 | $17.69M derived: sum of 3 quarters · filed 2026-08-10 | $24.02M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-03-31 | $5.57M 10-Q · filed 2026-05-11 | $11.78M derived: sum of 2 quarters · filed 2026-05-11 | $18.10M derived: sum of 3 quarters · filed 2026-05-11 | $25.36M derived: sum of 4 quarters · filed 2026-05-11 |
| 2024-12-31 | $6.21M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20 | $12.53M derived: sum of 2 quarters · filed 2026-02-20 | $19.79M derived: sum of 3 quarters · filed 2026-02-20 | $27.25M 10-K · filed 2026-02-20 |
| 2024-09-30 | $6.33M 10-Q · filed 2025-10-31 | $13.58M derived: sum of 2 quarters · filed 2025-10-31 | $21.05M 10-Q · filed 2025-10-31 | |
| 2024-06-30 | $7.25M 10-Q · filed 2025-08-11 | $14.72M 10-Q · filed 2025-08-11 | ||
| 2023-12-31 | $24.35M 10-K · filed 2026-02-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HENRY SCHEIN INC (HSIC) | United States | $9.536B | 23.59 |